docetaxel

You have access
Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma
MASANORI KOMATSU, YASUHIRO ARAI, KENICHIRO YABUKI, DAISUKE SANO, OSAMU SHIONO, YASUNORI SAKUMA, GOUSHI NISHIMURA, MASAHIRO TAKAHASHI, TAKAHIDE TAGUCHI and NOBUHIKO ORIDATE

Anticancer Research December 2015, 35 (12) 6861-6867;
You have access
Breast Cancer Cell Lines Exhibit Differential Sensitivities to Microtubule-targeting Drugs Independent of Doubling Time
APRIL L. RISINGER, NICHOLAS F. DYBDAL-HARGREAVES and SUSAN L. MOOBERRY

Anticancer Research November 2015, 35 (11) 5845-5850;
You have access
Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer Model
JACEK MACKIEWICZ, URSZULA KAZIMIERCZAK, MAREK KOTLARSKI, EWELINA DONDAJEWSKA, ANNA KOZŁOWSKA, ELIZA KWIATKOWSKA, ANITA NOWICKA-KOTLARSKA, HANNA DAMS-KOZŁOWSKA, PIOTR JAN WYSOCKI and ANDRZEJ MACKIEWICZ

Anticancer Research June 2015, 35 (6) 3275-3288;
You have access
Multi-center Randomized Phase II Study of Weekly Docetaxel Versus Weekly Docetaxel-plus-Oxaliplatin as a Second-line Chemotherapy for Patients with Advanced Gastric Cancer
JIN YOUNG KIM, HUN MO RYOO, SUNG HWA BAE, BYUNG WOOG KANG, YEE SOO CHAE, SHINKYO YOON, JIN HO BAEK, MIN KYOUNG KIM, KYUNG HEE LEE, SUN AH LEE, HONG SUK SONG and JONG GWANG KIM

Anticancer Research June 2015, 35 (6) 3531-3536;
You have access
The Role of PCA 3 as a Prognostic Factor in Patients with Castration-resistant Prostate Cancer (CRPC) Treated with Docetaxel
ANDREAS BOURDOUMIS, MICHAEL CHRISOFOS, THEODORA STASINOU, PANAGIOTIS CHRISTOPOULOS, PANAGIOTIS MOURMOURIS, ATHANASIOS KOSTAKOPOULOS and CHARALAMBOS DELIVELIOTIS

Anticancer Research May 2015, 35 (5) 3075-3079;
You have access
Preoperative Systemic and Intraperitoneal Chemotherapy Consisting of S-1, Cisplatin and Docetaxel in Patients with Marginally Resectable Gastric Cancer
YUKINORI KUROKAWA, TAKUYA HAMAKAWA, YASUHIRO MIYAZAKI, TSUYOSHI TAKAHASHI, MAKOTO YAMASAKI, HIROSHI MIYATA, KIYOKAZU NAKAJIMA, SHUJI TAKIGUCHI, MASAKI MORI and YUICHIRO DOKI

Anticancer Research April 2015, 35 (4) 2223-2228;
You have access
Neoadjuvant Docetaxel/Cyclophosphamide in Triple-negative Breast Cancer: Predictive Value of Class III-β Tubulin and Non-basal Subtype
KAZUHIRO SHIMADA, TAKASHI ISHIKAWA, KUMIKO KITA, KAZUTAKA NARUI, SADAYOSHI SUGAE, DAISUKE SHIMIZU, MIKIKO TANABE, TAKESHI SASAKI, TAKASHI CHISHIMA, YASUSHI ICHIKAWA and ITARU ENDO

Anticancer Research February 2015, 35 (2) 907-912;
You have access
Circulating Tumor Cells as a Biomarker Predictive of Sensitivity to Docetaxel Chemotherapy in Patients with Castration-resistant Prostate Cancer
TAKATSUGU OKEGAWA, NAOSHI ITAYA, HIDEHIKO HARA, MITSUHIRO TAMBO and KIKUO NUTAHARA

Anticancer Research November 2014, 34 (11) 6705-6710;
You have access
Docetaxel and Intermittent Erlotinib in Patients with Metastatic Non-small Cell Lung Cancer; A Phase II Study From The Hellenic Cooperative Oncology Group
VASILIOS KARAVASILIS, PARIS KOSMIDIS, KONSTANTINOS N. SYRIGOS, POLYXENI MAVROPOULOU, MELETIOS A. DIMOPOULOS, VASSILIKI KOTOULA, DIMITRIOS PECTASIDES, IOANNIS BOUKOVINAS, GEORGE KLOUVAS, ANNA KALOGERA-FOUNTZILA, CHRISTOS N. PAPANDREOU, GEORGE FOUNTZILAS and EVANGELOS BRIASOULIS

Anticancer Research October 2014, 34 (10) 5649-5655;
You have access
Clinical Outcome of Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
HYE SUNG WON, YOUN SOO LEE, EUN KYOUNG JEON, SOOK HEE HONG, JIN-HYOUNG KANG, YEON-SIL KIM, LE RYUNG YOO, DONG-IL SUN and MIN-SIK KIM

Anticancer Research October 2014, 34 (10) 5709-5714;

Main menu

User menu

Search

docetaxel

Pages